Millipore Sigma Vibrant Logo

197225 Bcl-2 Binding Peptide, Cell-Permeable, Negative Control - Calbiochem

概述

Replacement Information

重要规格表

Empirical Formula
C₁₅₀H₂₃₄N₄₄O₄₂S

价格及供货情况

产品目录编号 库存情况包装 数量 / 包装 价格 数量
197225-1MGCN
正在查询供货情况......
目前缺货
目前缺货
有货 
停产
少量现货
供货情况有待确认
    其余:另行通知
      其余:另行通知
      另行通知
      联系客户服务
      Contact Customer Service

      塑胶安瓿;塑胶针药瓶 1 mg
      正在检索价格......
      无法检索价格。
      最小订购数量为倍数
      Maximum Quantity is
      以订单确认为准 更多信息
      您节约了 ()。
       
      Request Pricing
      Description
      OverviewA cell-permeable, mutated cpm-1285 peptide analog (Leu151 replaced by Ala) that does not induce apoptosis and displays nearly 15-fold reduction in Bcl-2 binding. Suitable for use as a negative control for Cat. No. 197220.
      Catalogue Number197225
      Brand Family Calbiochem®
      Synonymscpm-1285m, Decanoyl-KN¹⁴⁰LWAAQRYGREARRMSDEFEGSFKGL¹⁶⁵-OH
      References
      ReferencesWang, J-L., et al. 2000. Cancer Res. 60, 1498.
      Product Information
      ATP CompetitiveN
      FormOff-white solid
      FormulationSupplied as a trifluoroacetate salt.
      Hill FormulaC₁₅₀H₂₃₄N₄₄O₄₂S
      Chemical formulaC₁₅₀H₂₃₄N₄₄O₄₂S
      Hygroscopic Hygroscopic
      ReversibleN
      Quality LevelMQ100
      Applications
      Biological Information
      Primary TargetA negative control for Cat. No. 197220 (Bcl-2 Binding Peptide, Cell-Permeable).
      Purity≥95% by HPLC
      Physicochemical Information
      Cell permeableY
      Peptide SequenceCH₃(CH₂)₈CONH-Lys-Asn-Leu-Trp-Ala-Ala-Gln-Arg-Tyr-Gly-Arg-Glu-Ala-Arg-Arg-Met-Ser-Asp-Glu-Phe-Glu-Gly-Ser-Phe-Lys-Gly-Leu-OH
      Dimensions
      Materials Information
      Toxicological Information
      Safety Information according to GHS
      Safety Information
      Product Usage Statements
      Storage and Shipping Information
      Ship Code Ambient Temperature Only
      Toxicity Standard Handling
      Storage -20°C
      Hygroscopic Hygroscopic
      Do not freeze Ok to freeze
      Special InstructionsFollowing reconstitution, aliquot, flush with an inert gas, and freeze at -20°C. Stock solutions are stable for up to 2 weeks at -20°C.
      Packaging Information
      Packaged under inert gas Packaged under inert gas
      Transport Information
      Supplemental Information
      Specifications
      Global Trade Item Number
      产品目录编号 GTIN
      197225-1MGCN 04055977206029

      Documentation

      Bcl-2 Binding Peptide, Cell-Permeable, Negative Control - Calbiochem MSDS

      职位

      物料安全数据表 (MSDS) 

      Bcl-2 Binding Peptide, Cell-Permeable, Negative Control - Calbiochem 分析证书

      标题批号
      197225

      参考

      参考信息概述
      Wang, J-L., et al. 2000. Cancer Res. 60, 1498.

      小册子

      标题
      Caspases and other Apoptosis Related Tools Brochure
      数据表

      Note that this data sheet is not lot-specific and is representative of the current specifications for this product. Please consult the vial label and the certificate of analysis for information on specific lots. Also note that shipping conditions may differ from storage conditions.

      Revision28-April-2008 RFH
      Synonymscpm-1285m, Decanoyl-KN¹⁴⁰LWAAQRYGREARRMSDEFEGSFKGL¹⁶⁵-OH
      DescriptionA cell-permeable, mutated cpm-1285 peptide analog where Leu151 is replaced by Ala. Does not induce apoptosis and displays about 15 fold lower Bcl-2 binding. Suitable for use as a negative control.
      FormOff-white solid
      FormulationSupplied as a trifluoroacetate salt.
      Intert gas (Yes/No) Packaged under inert gas
      Chemical formulaC₁₅₀H₂₃₄N₄₄O₄₂S
      Peptide SequenceCH₃(CH₂)₈CONH-Lys-Asn-Leu-Trp-Ala-Ala-Gln-Arg-Tyr-Gly-Arg-Glu-Ala-Arg-Arg-Met-Ser-Asp-Glu-Phe-Glu-Gly-Ser-Phe-Lys-Gly-Leu-OH
      Purity≥95% by HPLC
      SolubilityDMSO (10 mg/ml)
      Storage -20°C
      Hygroscopic
      Do Not Freeze Ok to freeze
      Special InstructionsFollowing reconstitution, aliquot, flush with an inert gas, and freeze at -20°C. Stock solutions are stable for up to 2 weeks at -20°C.
      Toxicity Standard Handling
      ReferencesWang, J-L., et al. 2000. Cancer Res. 60, 1498.